Therefore, we determined FAS expression by TMA and immunohistochemistry in HCC and paired adjacent non-neoplastic tissue to evaluate the correlation between PTEN loss and FAS overexpression in HCC. This evidence concerns the gene PTEN and hepatocellular carcinoma.